Gsa Capital Partners LLP Bridge Bio Pharma, Inc. Transaction History

Gsa Capital Partners LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$23.0 - $31.04 $492,683 - $664,907	21,421 New	21,421 $543,000
Q3 2023 Nov 15, 2023	BUY	$16.89 - $35.01 $1.45 Million - $3.01 Million	86,071 New	86,071 $2.27 Million
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $68,781 - $177,950	-9,593 Reduced 25.58%	27,908 $462,000
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $41,720 - $71,308	-6,190 Reduced 14.17%	37,501 $286,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $488,198 - $759,966	-61,486 Reduced 58.46%	43,691 $434,000
Q2 2022 Aug 09, 2022	BUY	$5.21 - $12.14 $365,554 - $851,790	70,164 Added 200.39%	105,177 $955,000
Q1 2022 May 11, 2022	BUY	$7.34 - $17.16 $155,050 - $362,487	21,124 Added 152.09%	35,013 $355,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $934,377 - $4.39 Million	-82,107 Reduced 85.53%	13,889 $232,000
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $3.97 Million - $5.44 Million	84,749 Added 753.53%	95,996 $4.5 Million
Q2 2021 Aug 05, 2021	BUY	$46.47 - $63.93 $522,648 - $719,020	11,247 New	11,247 $686,000
Q1 2021 May 10, 2021	SELL	$55.47 - $72.35 $576,055 - $751,354	-10,385 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$38.38 - $71.11 $2.67 Million - $4.94 Million	-69,505 Reduced 87.0%	10,385 $738,000
Q3 2020 Nov 06, 2020	BUY	$27.2 - $42.19 $2.17 Million - $3.37 Million	79,890 New	79,890 $3 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.